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days postinjury. At 48 hr, both vehicle-and AK295-treated injured animals showed significant neuromotor deficits (P < 0.005). At 7 days, injured animals that received vehicle continued to exhibit significant motor dysfunction (P < 0.01). However, brain-injured, AK295-treated animals showed markedly improved motor scores (P < 0.02), which were not significantly different from sham (uninjured) animals. Vehicle-treated, injured animals demonstrated a profound cognitive deficit (P < 0.001), which was significantly attenuated by AK295 treatment (P < 0.05). To our knowledge, this study is the first to use a calpain inhibitor following brain trauma and suggests that calpain plays a role in the posttraumatic events underlying memory and neuromotor dysfunction. Traumatic brain injury (TBI) results in delayed cell damage and death (1) (2) (3) subsequent to acute, widespread neuronal depolarization (4) and massive release of glutamate, as well as other excitatory amino acids (4) (5) (6) (7) . Activation of glutamate receptors with concomitant depolarization leads to calcium influx through ion channels associated with glutamate receptors, as well as through voltage-sensitive calcium channels. Cellular and tissue calcium levels are significantly elevated following experimental brain injury (8) (9) (10) (11) , and alterations in calcium flux persist for several days (10) . Calcium is thought to mediate a cytotoxic cascade through the activation of proteases, phospholipases, kinases, and phosphatases; impairment of mitochondrial function; and stimulation of excessive neurotransmitter release (12) (13) (14) . Cellular One logical target in such a downstream strategy is the nonlysosomal cysteine protease, calpain. Two isoforms of this protease are found in central nervous system tissues: calpain I, which is inactive until calcium concentrations reach micromolar levels, and calpain II, which is activated by near-millimolar free calcium (17) . Activation initiates limited autolysis of calpain subunits and lowers the calcium requirement for subsequent proteolysis (18) . Substrates for calpain include cytoskeletal proteins such as spectrin, tubulin, microtubuleassociated proteins, and neurofilament proteins (19) (20) (21) (22) (23) . In addition, calpain is capable of degrading enzymes (e.g., kinases, phosphatases) and membrane-associated proteins (e.g., ion channels and transporters, glutamate receptors, growth factor receptors, adhesion molecules) (24) . Consequently, activation of calpain produces irreversible structural and functional alterations that are hypothesized to be cytotoxic to neurons when calpain activation is prolonged and unregulated (25) (26) (27) (28) . Indeed, evidence accumulated over the past decade suggests that calpain proteolysis contributes to cytotoxicity in many forms of neurodegeneration, including ischemic brain damage, Alzheimer disease, spinal cord injury, and neural muscular degeneration (26, 29) . In models of cerebral ischemia, treatment with putative calpain inhibitors has afforded significant neuroprotection, supporting a role for calciuminduced proteolysis by calpain in the pathogenesis of acute ischemic injury (30) (31) (32) (33) (34) (35) . Recently, ketoamide calpain inhibitors have been shown to be neuroprotective even when administered after initiation of an ischemic event (30, 31) . Prolonged calpain activation was described after experimental brain injury in regions that correlate with neuronal degeneration and cell death (36) (31) . Briefly, the left common carotid artery was dissected free of the vagus nerve and surrounding fascia through a ventral midline cervical incision. The internal and external carotid arteries were exposed, and the external carotid artery was ligated -4 mm from the carotid bifurcation. An incision was made in the external carotid artery through which PE-10 tubing filled with 50 units/ml heparinized saline was inserted retrogradely -3 mm and secured with silk thread and tissue adhesive. This allowed for direct drug administration into the internal carotid artery without disturbing internal carotid artery blood flow.
Ninety minutes after anesthesia, one subgroup of animals (n = 31) was subjected to lateral FP injury of moderate severity (2.2-2.4 atm; 1 atm = 101.3 kPa) as described (39 (Fig. 1A) (Fig. 3A) . (Fig. 3B) . At 1 week after injury, no differences were observed between the sham and AK295-treated, injured animals (median = 19 and 17, respectively; P > 0.05), while the vehicle-treated, injured animals continued to exhibit a significant motor deficit (median = 11; P < 0.01). Importantly, the AK295-treated, injured animals showed significantly improved motor function when compared with vehicle-treated, injured animals (P < 0.02). Evaluation of Cognitive Function. Vehicle-treated, injured animals showed a profound and significant cognitive deficit (median = 52) when compared with sham animals (median = 172; P < 0.001) tested 1 week after injury (Fig. 4) . Treatment with AK295 significantly attenuated the posttraumatic cognitive dysfunction (median = 103; P < 0.02) when compared with vehicle treatment. During the memory test, the total distance swum by each of the sham animals (mean = 2620 ± 130 cm), the vehicle-treated, injured animals (mean = 2410 + 280 cm), and the AK295-treated, injured animals (mean = 2670 ± 370 cm) were not significantly different. (53, 54) . The degree of retrograde amnesia following lateral FP brain injury was correlated with the extent of bilateral neuronal loss in the dentate hilus (55) that, in addition to the ipsilateral CA3 region, is a primary site of selective, hippocampal neuronal damage (2, 45, 56, 57 (58, 59) and promoting retention of the capability for long-term potentiation following cerebral ischemia (34) . In addition, such inhibitors reduced hippocampal cell loss in the CA1 region in experimental models of cerebral ischemia (28, 33, 34) . Studies are needed to determine if calpain inhibitors, in addition to attenuating posttraumatic cognitive dysfunction, promote cell survival in hippocampal regions that typically exhibit delayed cell death following brain trauma.
In conclusion, postinjury administration of the calpain inhibitor AK295 produced significant attenuation of both motor and cognitive deficits associated with TBI in rats. These findings suggest that calpain plays an important role in the posttraumatic sequelae that lead to persistent neurobehavioral dysfunction, and indicate that the inhibition of calpain may be a beneficial therapeutic approach toward reducing posttraumatic morbidity.
